CHFS - CHF Solutions, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.20
0.00 (0.00%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close1.20
Open1.20
Bid1.05 x 1100
Ask1.21 x 900
Day's Range1.17 - 1.20
52 Week Range0.93 - 24.45
Volume37,306
Avg. Volume315,683
Market Cap8.489M
Beta3.98
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • GlobeNewswire3 days ago

    Recently Presented Data Demonstrate Benefits of CHF Solutions’ Aquadex FlexFlow® System in Managing Fluid Overload in Heart Failure Patients from the United Kingdom

    EDEN PRAIRIE, Minn., Sept. 20, 2018-- CHF Solutions, Inc. announced today results from a poster recently presented by a United Kingdom’ s National Health Service hospital that demonstrated ultrafiltration ...

  • GlobeNewswire10 days ago

    CHF Solutions Expands Commercial Focus of Fluid Overloaded Patients into the Post-Cardiovascular Surgery Market

    EDEN PRAIRIE, Minn., Sept. 13, 2018-- CHF Solutions, Inc., today announced that it is expanding its commercial focus into the post-cardiovascular surgery market, where, like in heart failure, patients ...

  • GlobeNewswire12 days ago

    CHF Solutions, Inc. to Attend the 22nd Annual Scientific Meeting of the Heart Failure Society of America

    CHF Solutions, Inc. (CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow system for Aquapheresis therapy. The Aquadex FlexFlow® system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.

  • GlobeNewswire18 days ago

    CHF Solutions, Inc. Acquires Impedance Technology from Vasamed, Inc.

    EDEN PRAIRIE, Minn., Sept. 05, 2018-- CHF Solutions, Inc. announced today it has acquired the AcQtrac™ System technology from Vasamed, Inc. The AcQtrac System is a patented, non-invasive device designed ...

  • GlobeNewswirelast month

    CHF Solutions, Inc. Completes In-House Manufacturing Capabilities with Initiation of Catheter Production

    EDEN PRAIRIE, Minn., Aug. 23, 2018-- CHF Solutions, Inc., today announced it has now completed the transition of all manufacturing activities related to Aquadex FlexFlow ® with the initiation of in-house ...

  • GlobeNewswirelast month

    CHF Solutions, Inc. Extends Reach in Asia with Distribution in Thailand

    EDEN PRAIRIE, Minn., Aug. 21, 2018-- CHF Solutions, Inc. announced today that the company received registration from FDA Thailand to allow the sale of Aquadex Flex Flow ® in Thailand. The product will ...

  • GlobeNewswirelast month

    CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    CHF Solutions, Inc. (CHFS), today announced that on August 15, 2018, the independent directors approved seven equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to seven individuals entering into employment with the Company.  The equity awards were approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder approved equity plan. In connection with entering into employment with CHF Solutions, the seven individuals, who were not previously employees or directors of CHF Solutions, received options to purchase an aggregate of 169,440 shares of the Company’s common stock. CHF Solutions, Inc. (CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow system for Aquapheresis® therapy.

  • GlobeNewswire2 months ago

    CHF Solutions, Inc. Announces 27% Revenue Growth for its Second Quarter and Provides Company Update

    EDEN PRAIRIE, Minn., Aug. 07, 2018-- CHF Solutions, Inc. announced today its second quarter results for the period ended June 30, 2018. Revenue for second quarter ended June 30, 2018 increased 27 percent ...

  • ACCESSWIRE2 months ago

    CHF Solutions Inc to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 7, 2018 / CHF Solutions Inc (NASDAQ: CHFS ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 7, 2018 at 9:00:00 AM Eastern Time. ...

  • GlobeNewswire2 months ago

    CHF Solutions, Inc. To Announce Second Quarter Financial Results on August 7, 2018

    EDEN PRAIRIE, Minn., July 31, 2018-- CHF Solutions, Inc. announces today that its second quarter 2018 financial results will be released on Tuesday, August 7, 2018. The company will host a conference call ...

  • GlobeNewswire2 months ago

    Department of Veterans Affairs Awards a $6.5 million Blanket Purchase Agreement to CHF Solutions to Supply Aquadex FlexFlow System for Outpatient Services in Tampa, Fla.

    EDEN PRAIRIE, Minn., July 25, 2018-- As previously disclosed on its website, FedBizOps.gov, the United States Department of Veterans Affairs has awarded CHF Solutions, Inc. a blanket purchase agreement ...

  • GlobeNewswire2 months ago

    CHF Solutions, Inc. Enters the German Market

    EDEN PRAIRIE, Minn., July 12, 2018-- CHF Solutions, Inc., today announces it has entered into the German market by expanding a relationship with HSC-Medical, GmbH, a business solutions resource based in ...

  • GlobeNewswire3 months ago

    CHF Solutions, Inc. Announces Closing of Common Stock Offering

    The offering was made pursuant to a shelf registration statement on Form S-3 (File No. 333-224881) that was filed by the company with the Securities and Exchange Commission (SEC) and was declared effective on May 23, 2018.  A preliminary prospectus supplement and accompanying prospectus relating to the offering was filed with the SEC and a final prospectus supplement and the accompanying prospectus relating to this offering were filed with the SEC. Copies of the final prospectus supplement and the accompanying prospectus relating to and describing the terms of the offering may be obtained from Ladenburg Thalmann & Co. Inc., 277 Park Avenue, 26th Floor, New York, NY 10172, or by email at prospectus@ladenburg.com.

  • GlobeNewswire3 months ago

    CHF Solutions, Inc. Announces Pricing of Common Stock Offering

    CHF Solutions, Inc. (CHFS) today announced the pricing of an underwritten public offering of 2,214,930 shares of its common stock at a price to the public of $2.12 per share, for gross proceeds of approximately $4.7 million prior to deducting underwriting discounts and commissions and offering expenses payable by CHF Solutions.  CHF Solutions has granted the underwriters an option, exercisable in whole or in part for 45 days, to purchase up to an additional 332,239 shares of its common stock at the public offering price, less the underwriting discounts and commissions. Ladenburg Thalmann & Co. Inc., a subsidiary of Ladenburg Thalmann Financial Services Inc. (NYSE American:LTS), is acting as sole book-running manager in connection with the offering.

  • ACCESSWIRE3 months ago

    Free Research Reports on Boston Scientific and Three More Medical Equipment Stocks

    Today's research coverage on WallStEquities.com is focused on four Medical Appliances and Equipment stocks, particularly, Boston Scientific Corp. (NYSE: BSX), Cesca Therapeutics Inc. (NASDAQ: KOOL), CHF Solutions Inc. (NASDAQ: CHFS), and Intuitive Surgical Inc. (NASDAQ: ISRG).